AstraZeneca: Accelerating Drug Discovery with Machine Learning and AI on Cambridge-1



AstraZeneca is powering modern #machinelearning (ML) and AI to accelerate drug discovery with Cambridge-1, training models to learn the grammar of chemistry, and processing whole slide digital pathology images.

Learn more about #healthcare and life sciences research on NVIDIA Cambridge-1: https://nvda.ws/3yPKmf1

Scroll to Top

Discover more from WDN

Subscribe now to keep reading and get access to the full archive.

Continue reading